Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 25, 2021

View Archived Issues

Understanding DNA repair mechanisms allows for crisper CRISPR genome editing

Biallelic variants in the KARS1 gene tied to neurodevelopmental disorders and hearing loss

CHD8 haploinsufficiency leads to seizure phenotype

Bayer and collaborators describe new EGFR inhibitors

Monash University divulges antibiotic peptide-drug conjugates

PKMYT1 inhibitors discovered at Repare Therapeutics

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent GLP-1 receptor agonists

Shanghai Synergy Pharmaceutical Sciences, Zhejiang Huahai Pharmaceutical identify kinase inhibitors

Novel mouse model of spontaneously occurring endometriosis created

Fusion Pharmaceuticals evaluates alpha particle-emitting NTSR1 antagonist for colorectal cancer

AAV9-Galns gene therapy corrects mucopolysaccharidosis type IVA pathology in vivo

Novel PSMA-targeting ligand PSMA-TO-1 shows prolonged circulation time and higher tumor uptake

ABHD16A deficiency linked to subtype of complicated hereditary spastic paraplegia

Gene-protein-disease map reveals connections within and between diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...